SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR-46.7%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
-46.7%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
20254.72%
2024-14.31%
2023-0.48%
202231.12%
202116.13%
2020-8.15%
20190.00%